C Jersild

479 total citations
11 papers, 377 citations indexed

About

C Jersild is a scholar working on Immunology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, C Jersild has authored 11 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Pathology and Forensic Medicine and 3 papers in Hematology. Recurrent topics in C Jersild's work include Multiple Sclerosis Research Studies (4 papers), Immunotherapy and Immune Responses (3 papers) and T-cell and B-cell Immunology (3 papers). C Jersild is often cited by papers focused on Multiple Sclerosis Research Studies (4 papers), Immunotherapy and Immune Responses (3 papers) and T-cell and B-cell Immunology (3 papers). C Jersild collaborates with scholars based in Denmark. C Jersild's co-authors include Bo Dupont, Robert Winchester, Shu Man Fu, Peter Wernet, Henry G. Kunkel, Fog T, Niels Grunnet, Arne Svejgaard, Søren Krogh Jensen and Carolyn Whitsett and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Vox Sanguinis.

In The Last Decade

C Jersild

11 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Jersild Denmark 7 250 98 78 64 43 11 377
Richard T. Callery United States 7 217 0.9× 73 0.7× 36 0.5× 30 0.5× 41 1.0× 8 340
I. Schreuder Netherlands 13 271 1.1× 90 0.9× 26 0.3× 57 0.9× 53 1.2× 21 464
Satoshi Shiokawa Japan 10 227 0.9× 100 1.0× 57 0.7× 38 0.6× 65 1.5× 24 375
C Thielemans Belgium 5 180 0.7× 71 0.7× 41 0.5× 33 0.5× 44 1.0× 6 333
Herbert Begemann Germany 9 132 0.5× 25 0.3× 59 0.8× 70 1.1× 60 1.4× 48 355
S Scholz Germany 5 254 1.0× 82 0.8× 20 0.3× 41 0.6× 39 0.9× 10 356
A.J. Hannema Netherlands 9 228 0.9× 100 1.0× 17 0.2× 61 1.0× 101 2.3× 18 383
B. Heilig Germany 10 197 0.8× 60 0.6× 35 0.4× 144 2.3× 110 2.6× 24 488
Shaoxian Zhu United States 7 198 0.8× 177 1.8× 55 0.7× 119 1.9× 103 2.4× 8 396
Dorothea Stahl France 10 189 0.8× 122 1.2× 27 0.3× 50 0.8× 106 2.5× 23 341

Countries citing papers authored by C Jersild

Since Specialization
Citations

This map shows the geographic impact of C Jersild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Jersild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Jersild more than expected).

Fields of papers citing papers by C Jersild

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Jersild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Jersild. The network helps show where C Jersild may publish in the future.

Co-authorship network of co-authors of C Jersild

This figure shows the co-authorship network connecting the top 25 collaborators of C Jersild. A scholar is included among the top collaborators of C Jersild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Jersild. C Jersild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Jensen, Søren Krogh, C Jersild, & Niels Grunnet. (1990). Severe Transfusion Reaction to Donor Plasma Containing HLA Antibody. Vox Sanguinis. 59(1). 62–62. 10 indexed citations
2.
Lindhardt, Bjarne Ørskov, K. Ulrich, Lars P. Ryder, et al.. (1986). HTLV‐III Antibody Testing in Three Danish Blood Banks. Vox Sanguinis. 51(s1). 9–14. 15 indexed citations
3.
Jersild, C. (1978). Studies of HLA antigens in multiple sclerosis.. PubMed. 56(6). 516–30. 6 indexed citations
4.
Dupont, Bo, C Jersild, John A. Hansen, et al.. (1977). HLA antigens in black American patients with multiple sclerosis.. PubMed. 9(1 Suppl 1). 181–5. 19 indexed citations
5.
Cunningham‐Rundles, Charlotte, et al.. (1977). Are HLA and Chido related antigenic groups?. PubMed. 9(1 Suppl 1). 33–7. 1 indexed citations
6.
Ja, Hansen, Young Cw, Carolyn Whitsett, et al.. (1977). HLA and MLC typing in patients with Hodgkin's disease.. PubMed. 16. 217–27. 5 indexed citations
7.
Jersild, C. (1977). The major histocompatibility system, HLA, and multiple sclerosis.. PubMed. 63. 17–21. 4 indexed citations
8.
Winchester, Robert, Peter Wernet, Henry G. Kunkel, et al.. (1975). Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes.. The Journal of Experimental Medicine. 141(4). 924–929. 275 indexed citations
9.
Jersild, C, et al.. (1975). Evidence for tryosine peptide homologies in the HLA antigens system.. Proceedings of the National Academy of Sciences. 72(12). 5081–5085. 4 indexed citations
10.
Jersild, C, et al.. (1973). Histocompatibility-linked immune-response determinants in multiple sclerosis.. PubMed. 5(4). 1791–6. 18 indexed citations
11.
Jersild, C & Fog T. (1972). Histocompatibility (HL-A) antigens associated with multiple sclerosis.. PubMed. 51. 377–377. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026